Phase I/II trial of CTX-001 in Beta-thalassaemia
Latest Information Update: 01 Mar 2019
At a glance
- Drugs Exagamglogene autotemcel (Primary)
- Indications Beta-thalassaemia
- Focus Therapeutic Use
Most Recent Events
- 01 Mar 2019 New trial record
- 25 Feb 2019 According to the CRISPR Therapeutics media release, company plan to begin enrollment this year.